Keywords: Sanofi, Lyxumia, Lixisenatide, Japanese filing, Zealand Pharma

Sanofi files for Japanese approval of diabetes drug Lyxumia

Article | 11 June 2012

French drug major Sanofi (Euronext: SAN), has submitted a marketing authorization application for lixisenatide (the proposed trade name in Europe ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Sanofi

Zealand Pharma

Go to company listing

Related Drugs

lixisenatide

Lyxumia

Go to drug listing